top of page
DNA
ACT1 | BRAF | CDK12 | EGFR | ERBB2 | FGFR1 | FGFR2 | FGFR3 | HRAS | IDH1 | PTEN | TP53 | TSC1 | KRAS | MTOR | NRAS | NTRK1 | NTRK3 | TSC2 |
FUSION
NTRK1 Fusion | NTRK2 Fusion | NTRK3 Fusion | RET Fusion | PD-L1 IHC | MGMT Hypermethylation | Microsatellite Instability (MSI) |
Method: Next Generation Sequencing (NGS)
Sample Type: Tissue, Blood (Liquid Biopsy Tube)
Result Time: 20-25 Days
Sensitivity: 99%
Description: 19 Genes - 4 Fusions + MSI + PD-L1 IHC + MGMT Hypermethylation

GLIOMA PLUS PANEL
✓ Paraffin Block ✓ Liquid Biopsy

GLIOMA PLUS PANEL
With the latest update made by the World Health Organization in the classification of brain tumors, advanced genetic analysis is required to determine tumor types. As a result of the analysis, targeted treatment options can be offered according to tumor types.
bottom of page